CVS Health raises 2026 guidance after Q1 earnings beat

CVS Health raised its full-year 2026 nett forecast connected Wednesday aft first-quarter results topped Wall Street estimates, driven by improved aesculapian outgo controls astatine its Aetna security unit.

For the afloat year, CVS present targets adjusted net per stock betwixt $7.30 and $7.50, compared with erstwhile guidance of $7.00 to $7.20. Full-year gross guidance was raised to astatine slightest $405 cardinal from astatine slightest $400 billion. Cash travel from operations guidance besides accrued to astatine slightest $9.5 cardinal from astatine slightest $9.0 billion.

First-quarter gross reached $100.4 billion, a 6.2% year-over-year increase, with CVS reporting adjusted net of $2.57 per share. Wall Street had penciled successful adjusted net of $2.20 per stock and gross of $95.09 billion, based connected expert surveys cited by CNBC.

With the results, CVS extended its tally of topping Street expectations to 5 consecutive quarters, according to Reuters. A CEO alteration had travel successful 2024, a twelvemonth erstwhile the institution repeatedly fell abbreviated of Wall Street expectations.

The clearest motion of advancement came from Aetna, CVS's wellness security segment. Aetna's aesculapian payment ratio, which tracks however overmuch of collected premiums spell toward paying claims, came successful astatine 84.6%, down from 87.3% successful the prior-year period. When that fig declines, it indicates the insurer is retaining much of its premium gross aft covering aesculapian expenses. Analysts had expected a ratio of 86.3%, according to CNBC. Adjusted operating income for the conception roseate 52.6% to $3.04 billion.

CFO Brian Newman pointed to amended interior forecasting tools and structural changes wrong Aetna arsenic cardinal reasons for the improved results. "We're improving our capableness of forecasting, truthful the outgo inclination did not astonishment me," Newman told Reuters. While aesculapian costs person not travel down, Newman said the institution is deploying interior initiatives aimed astatine trimming operational expenses.

Newman told CNBC that Aetna's momentum — which helium described arsenic "the tailwinds we're seeing" — accounts for the bulk of the raised gross target, adjacent arsenic the institution keeps a cautious oculus connected persistently precocious aesculapian costs for the remainder of the year.

Revenue from the wellness services segment, location to pharmacy payment manager Caremark, totaled $48.24 billion, an 11% leap compared with the aforesaid 4th past year. A much profitable premix of drugs boosted net astatine Caremark, Newman said.

Sales astatine the pharmacy and user wellness division, covering astir 9,000 store locations, came to $31.99 billion, small changed from the year-ago quarter. Adjusted operating income successful that conception dropped 8.8%, arsenic the portion absorbed headwinds from tighter pharmacy reimbursements, government-mandated cause pricing adjustments, a lighter flu season, and impermanent closures caused by wintertime weather, CVS said.